MedTrace Logo

Improving Antihypertensive and Lipid-Lowering Therapy

NCT00876330 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6000

Last updated 2012-09-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of electronic health record clinical decision support and automated telephone outreach on antihypertensive and lipid-lowering therapy in ambulatory care.

Conditions

Interventions

OTHER

Clinical Decision Support for Hypertension

Clinical decision support alerts for antihypertensive therapy

OTHER

Automated Telephone Outreach for Antihypertensive Therapy

Automated Telephone Outreach to patients for antihypertensive medication therapy.

OTHER

Clinical Decision Support for Lipid-lowering Therapy

Clinical Decision Support alerts for Lipid-lowering medication therapy.

OTHER

Automated Telephone Outreach for Lipid-lowering Therapy

Automated telephone outreach to patients for Lipid-lowering medication therapy.

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • VA Boston Healthcare System

    lead FED

Principal Investigators

  • Steven R Simon, MD, MPH · Brigham and Women's Hospital

  • David W Bates, MD, MSc · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-12-31
Completion
2013-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00876330 on ClinicalTrials.gov